Allergic Rhinitis News and Research

RSS
Zabecor Pharmaceuticals initiates Phase II clinical trial of its Excellair asthma drug

Zabecor Pharmaceuticals initiates Phase II clinical trial of its Excellair asthma drug

Azelastine and fluticasone combination for allergic rhinitis gets new lease

Azelastine and fluticasone combination for allergic rhinitis gets new lease

Sepracor to be acquired by Dainippon Sumitomo Pharma for $2.6 billion

Sepracor to be acquired by Dainippon Sumitomo Pharma for $2.6 billion

FDA approves Meda's ASTEPRO Nasal Spray

FDA approves Meda's ASTEPRO Nasal Spray

FDA approves Astepro nasal spray 0.15% for the treatment of the symptoms of seasonal allergies

FDA approves Astepro nasal spray 0.15% for the treatment of the symptoms of seasonal allergies

Nuvo Research's co-operative drug development project with Fraunhofer Institute for developing WF10

Nuvo Research's co-operative drug development project with Fraunhofer Institute for developing WF10

Herbalscience research throws light on causes of allergic rhinitis

Herbalscience research throws light on causes of allergic rhinitis

Morria Biopharmaceuticals receives approval to commence its Phase II clinical trial on MRX6

Morria Biopharmaceuticals receives approval to commence its Phase II clinical trial on MRX6

UCB and sanofi-aventis U.S. receive FDA's approval for XYZAL to treat allergies in children

UCB and sanofi-aventis U.S. receive FDA's approval for XYZAL to treat allergies in children

U.S.District Court ruling favors Merck in patent infringement suit against Teva Pharmaceuticals

U.S.District Court ruling favors Merck in patent infringement suit against Teva Pharmaceuticals

Amira Pharmaceuticals submits IND for inflammatory and allergic disease treatment candidate

Amira Pharmaceuticals submits IND for inflammatory and allergic disease treatment candidate

Two American Oriental Bioengineering products bag China's Top Branded Drugs of 2009 award

Two American Oriental Bioengineering products bag China's Top Branded Drugs of 2009 award

Schering-Plough announces agreement with Orchid Chemicals & Pharmaceuticals on generic forms of CLARINEX

Schering-Plough announces agreement with Orchid Chemicals & Pharmaceuticals on generic forms of CLARINEX

Innovative Virtual Patient system for allergy sufferers

Innovative Virtual Patient system for allergy sufferers

Orexo reports on efficacy study in allergic rhinitis with OX914

Orexo reports on efficacy study in allergic rhinitis with OX914

Broccoli and other cruciferous vegetables may protect against asthma, allergic rhinitis and COPD

Broccoli and other cruciferous vegetables may protect against asthma, allergic rhinitis and COPD

Questions of ethics and quality cloud globalization of clinical trials

Questions of ethics and quality cloud globalization of clinical trials

Allergic rhinitis not associated with snoring or daytime sleepiness

Allergic rhinitis not associated with snoring or daytime sleepiness

New advances in diagnosis and treatment of allergic diseases

New advances in diagnosis and treatment of allergic diseases

Efficacy, dosage concerns unresolved on sublingual immunotherapy

Efficacy, dosage concerns unresolved on sublingual immunotherapy